Table 5 Socioeconomic differences in the utilization of antimalarials by pregnant women
Antimalarials used for treatment of fever | Q1 (%) | Q2 (%) | Q3 (%) | Q4 (%) | Q5 (%) | Q1:Q5 | Chi square (p value) |
|---|---|---|---|---|---|---|---|
Children less than five years | |||||||
ACTs | 9(28) | 13(29) | 13(33) | 29(43) | 27(26) | 1.1 | 5.97(0.20) |
Chloroquine | 0(0) | 1(2) | 0(0) | 0(0) | 2(2) | 0 | 2.85(0.58) |
Quinine | 0(0) | 0(0) | 1(2.6) | 1(1.5) | 1(1) | 0 | 1.83(0.77) |
Sulfadoxine-pyrimethamine | 7(21) | 11(24) | 8(21) | 13(19) | 22(21) | 1 | 0.42(0.98) |
Artesunate monotherapy | 1(3) | 2(4) | 5(13) | 4(6) | 9(9) | 0.3 | 3.69(0.45) |
Others | 5(15) | 4(9) | 7(18) | 7(10) | 6(6) | 2.5 | 5.61(0.23) |
Pregnant women for treatment of malaria | |||||||
ACTs | 10(27) | 16(28) | 15(34) | 36(48) | 42(38) | 0.71 | 7.66(0.11) |
Chloroquine | 0(0) | 0(0) | 0(0) | 0(0) | 1(1) | 0.0 | 1.94(0.75) |
Quinine | 1(3) | 0(0) | 1(2.3) | 1(1.3) | 2(2) | 1.49 | 1.45(0.84) |
Sulfadoxine-pyrimethamine | 10(27) | 21(37) | 14(32) | 16(21) | 30(27) | 0.99 | 4.21(0.38) |
Artesunate monotherapy | 0(0) | 1(2) | 0(0) | 1(1) | 1(1) | 0.0 | 1.32(0.86) |
Others | 10(27) | 5(9) | 11(25) | 12(16) | 6(5) | 4.95 | 18.09(0.001) |